Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

1 May 2012
by Working Group

Posted in Announcements, Events, TB News

Watch Video from the World TB Day Congressional Briefing

congress-hearing

A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV. Links to video included.

Community Engagement through Drama

gillian-blackb

Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF). In this inteview, we discuss with Dr. Black one of SLF’s groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS.

29 Mar 2012
by Working Group

Posted in Announcements, TB Drug Development, TB News

Working Group on New TB Drugs Launches Strategic Plan 2011-2015

Click here to access publication.

The WGND Strategic Plan 2011-2015 is an update of the “New Drugs” section of the Global Plan to Stop TB: 2011-2015. It describes the progress, gaps, and vision of the WGND and the TB drug development field as a whole.

23 Mar 2012
by Working Group

Posted in Action, Announcements, Events, TB News

World TB Day! Overview of Events, News and Messages

wtd2012

Saturday, March 24, is officially World TB Day but there has been a stream of activities, publications, news and messages to let the world not forget about this major infectious disease killer that claims millions of lives each year. We present links and summaries of events, publications, messages, and news coverage leading up to World TB Day.

21 Mar 2012
by Working Group

Posted in Announcements, Events, TB Drug Development, TB News

World TB Day Coverage: New Combo TB Drug Trial Announced

img_0842

During the “Cure All: A briefing on the status of the most promising new TB drugs research” sponsored by the Critical Path to New TB Drug Regimens (CPTR) on Monday, March 19, Dr. Mel Spigelman, CEO & President, of TB Alliance announced the launch of the NC002 trial, a combination drug trial that establishes a new pathway to TB and multi-drug resistant TB treatment. The meeting also involved high-level officials from U.S. agencies that support TB research including Anthony Fauci (Director, NIAID/NIH), Janet Woodcock (Director, CDER/FDA), and Robert Clay (Deputy Assistant Administrator, Global Health Bureau/USAID).

6 Mar 2012
by Working Group

Posted in Announcements, TB News

Death of TB Champion, Rep. Donald Payne

Payne

U.S. Representative Donald Payne from New Jersey died Tuesday, March 6. He will be remembered as a great champion of TB as well as malaria and HIV/AIDS.

31 Jan 2012
by Working Group

Posted in Action, Announcements, Events, TB News

News from the 21st Stop TB Partnership Coordinating Board Meeting, Bangkok

stop tb

he 21st Stop TB Partnership Coordinating Board retreat and meeting officially started in Bangkok, Thailand, on Sunday, January 29th with the official opening ceremony held yesterday January 30th. Included are some exciting news from the meeting courtesy of Mark Harrington, Executive Director of the Treatment Action Group (TAG).

Kick TB Campaign: Scoring Big in South Africa and Beyond

soccerballFront-300x290

The Kick TB Campaign is a unique project that uses the World’s most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).

13 Jan 2012

TB R&D Weekly Update: Totally Drug-Resistant TB

bacteria

Over the past couple of weeks there have been much discussion and reporting on totally drug-resistant tuberculosis (TDR-TB) based on reports of new cases in India. Here are links to coverage of TDR-TB in India, excerpt from a response by Dr. Nardell who we interviewed last year, and link to the WHO Fact Sheet on TDR-TB. Additional links to TB R&D News are included.

8 Dec 2011
by Heather_Ignatius

Posted in Action, Announcements, Front Lines of TB R&D, TB News

4th Annual G-FINDER Survey Released

gfinderjpg

Today, the fourth annual G-FINDER survey tracking funding for research and development of neglected disease technologies was released. This year’s report shows that funding for product development is on the decline and product development partnerships (PDPs) have been particularly hard hit, as eight of the top twelve public donors cut their funding in 2010. Now is a time of tremendous opportunity, with dozens of potential products within the reach of patients–donors must commit to taking them across the finish line.